Medical Oncology & Hematology at The Center for Cancer and Blood Disorders. Trained at UT Southwestern in Dallas, Tx. Tweets are my own and not medical advice.
#ASCO25 Final results of IO-based combinations in mRCC are in! See below and subsequent posts for thoughts. Video discussing these data coming soon from @OncoAlert...
North Texas Giving Day 2022!!! Don’t forget to support your favorite non profits. Here is the link for this event:
https://t.co/39JlDId7Xv
Arlington friends, go vote for the Arlington Tomorrow Foundation People’s Choice Awards.
https://t.co/MN7OaIY21b
Bad Bunny was easily the best concert I have been to! It was the best early birthday present! I am so glad to have shared this with you, Catherine Parra #badbunny
✅Do ALL renal cell cancer patients require adjuvant Pembrolizumab after nephrectomy? Dr. Katy Beckermann provides a masterful discussion at our Masters Lecture Series.
@OncoAlert
Honored to be a finalist in @ArlingtonToday magazine for best Oncologist in Arlington. I am truly grateful and humbled. Congratulations to all the other physicians!
The American Cancer Society reported earlier this year that the risk of dying from cancer in the United States has decreased by 32% over the past 28 years, which translates to almost 3.5 million fewer cancer deaths. #oncology#MedTwitter https://t.co/Zik7txqfhS
Omicron's lethality rate among seniors was worse than Delta
https://t.co/DqZooPJKva
The waning of vaccinations, lack of adequate booster uptake in this high-risk age group were contributory factors